Skip to content
Excited old Indian patient man and happy young doctor woman using digital tablet together, looking at display, talking, discussing HbA1c medical test results, modern electronic diagnosing

HbA1c results in 5 minutes

Simplified fully automated point-of-care system providing reliable HbA1c results within minutes, designed for health care professionals

Are you looking for ways to enhance diabetes care with efficient point-of-care testing?

Get the opportunity to improve your patients’ outcomes in primary care with point-of-care testing for diabetes management. Optimize prescribing decisions, reduce referrals, improve efficiency of care, and decrease costs.1

Test HbA1c with our fast, easy and reliable point-of-care system. With the HemoCue® HbA1c 501 System, you can count on getting the right answer at the right time, so you don’t miss a beat when caring for your diabetic patients.

Contact us

What is diabetes?

Male Doctor talking to female patient at Doctors Office

 

 

 

Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which over time may lead to damage to the heart, blood vessels, eyes, kidneys and nerves.2

The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resistant to insulin or doesn’t make enough insulin. In the past 3 decades the prevalence of type 2 diabetes has risen dramatically in countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself. For people living with diabetes, access to affordable treatment, including insulin, is critical to their survival. There is a globally agreed target to halt the rise in diabetes and obesity by 2025.

About 830 million people worldwide have diabetes, the majority living in low-and middle-income countries. More than half of people living with diabetes are not receiving treatment. Both the number of people with diabetes and the number of people with untreated diabetes have been steadily increasing over the past decades.2

Read more

Lowering your patients’ HbA1c by just 1% can result in significant changes 2,3,4

  • 76 % decrease of eye disease

  • 14 % decrease of myocardinal infarction

  • 50 % decrease in kidney failure

Illustraton of diabetes complications

The HemoCue® HbA1c 501 Analyzer offers lab-quality results in four simple steps

Step 3 - How to use the HemoCue® HbA1c 501 System
01

Insert cartridge into compartment

Step 2 - How to use the HemoCue® HbA1c 501 System
02

Fill the reagent pack

Step 1 - How to use the HemoCue® HbA1c 501 System
03

Insert reagent pack into cartridge

Step 4 - How to use the HemoCue® HbA1c 501 System
04

View results after 5 minutes

Contact us to learn more

HemoCue® HbA1c 501 System

HbA1c monitoring analyzer in doctors office

 

The HemoCue® HbA1c 501 System is a fully automated point-of-care system for testing HbA1c. Providing reliable results within 5 minutes, you can follow up with your patient straight away, transforming your entire work process.

Go to the product page to learn more

References

1 American Diabetes Association; 6. Glycemic Targets. Diabetes Care 1 January 2015; 38 (Supplement_1): S33–S40.
2 World Health Organization (WHO). Health Topics diabetes. https://www.who.int/health-topics/diabetes#tab=tab_1. Accesses April 8, 2025.
3 Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.
4 Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405-12.
5 De Boer IH; DCCT/EDIC Research Group. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):24-30.